New ACCF/AHA/SCAI Guidelines With Increased Recommendations for the Use of Extracorporeal Hemodynamic Support in Patients With Cardiac or Cardio-Pulmonary Failure

AMPFING, Germany, January 17, 2012 /PRNewswire/ –

LIFEBRIDGE Medizintechnik AG today announces increased recommendations for hemodynamic
support by guidelines for percutaneous coronary interventions (PCI). Issued by the
American College of Cardiology Foundation (ACCF), the American Heart Association (AHA) and
the Society for Coronary Angiography and Interventions (SCAI), guidelines provide expanded
recommendations for hemodynamic support in patients with cardiogenic shock, during
high-risk PCIs and to stabilize emergent patients in hospitals without on-site cardiac
surgery. The innovative portable LIFEBRIDGE system, with its clinically proven capability
to completely substitute cardiac function and oxygenate emergency patients, is the ideal
cardiopulmonary support system for PCI centers to fulfill the updated guideline
recommendations.

The 2011 ACCF/AHA/SCAI guidelines incorporate hemodynamic support for:

Class I: Cardiogenic Shock

“A hemodynamic support device is recommended for patients with cardiogenic shock after
STEMI who do not quickly stabilize with pharmacological therapy.”(Level of Evidence B)

Class IIb: Adjunctive Therapeutic Devices: Percutaneous Hemodynamic Support Devices:

“Elective insertion of an appropriate hemodynamic support device as an adjunct to PCI
may be reasonable in carefully selected high-risk patients.”(Level of Evidence: C)

Class III: HARM: PCI in Hospitals Without On-Site Surgical Backup:

“Primary or elective PCI should not be performed in hospitals without on-site cardiac
surgery capabilities without a proven plan for rapid transport to a cardiac surgery
operating room in a nearby hospital or without appropriate hemodynamic support capability
for transfer.”(Level of Evidence: C)

“Minimizing the time to initiation of cardiopulmonary bypass in patients requiring
extracorporeal support now, for the first time, has been fully addressed by the updated
PCI guidelines,” said Professor Hans-Reinhard Zerkowski, cardiac surgeon and CEO of
LIFEBRIDGE Medizintechnik AG. “The portable LIFEBRIDGE system is a unique solution for
advanced life support in PCI centers and best suited to fulfill the updated guideline
recommendations. Together with its unique safety features and usability LIFEBRIDGE
markedly will improve the standard of care in cardiac and respiratory emergencies.”

An extended version of the press release and additional information are available
online: http://www.lifebridge.de/cms/front_content.php?idart=425&idcat=176&lang=6

        CONTACT
        Kypp Morrow, President, LIFEBRIDGE North America Inc.
        phone: +1(617)3069893
        FAX: +1(215)6284529
        e-mail: k.morrow@lifebridge.com

SOURCE LIFEBRIDGE Medizintechnik AG